Cargando…
Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects
Bladder cancer is one of the most prevalent cancers. Despite recent advancements in bladder cancer therapy, new strategies are still required for improving patient outcomes, particularly for those who experienced Bacille Calmette–Guerin failure and those with locally advanced or metastatic bladder c...
Autores principales: | Hu, Henglong, Xia, Qidong, Hu, Jia, Wang, Shaogang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738443/ https://www.ncbi.nlm.nih.gov/pubmed/36498574 http://dx.doi.org/10.3390/jcm11236997 |
Ejemplares similares
-
Oncolytic Viruses in the Treatment of Bladder Cancer
por: Potts, Kyle G., et al.
Publicado: (2012) -
Comprehensive Analysis of Senescence Characteristics Defines a Novel Prognostic Signature to Guide Personalized Treatment for Clear Cell Renal Cell Carcinoma
por: Zhou, Peng, et al.
Publicado: (2022) -
Oncolytic Viruses for Canine Cancer Treatment
por: Sánchez, Diana, et al.
Publicado: (2018) -
Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development Directions
por: Luo, Dankun, et al.
Publicado: (2022) -
Oncolytic viruses as immunotherapy: progress and remaining challenges
por: Aurelian, Laure
Publicado: (2016)